Latest News
-
Nearly one billion people could be living with osteoarthritis by 2050
Posted on:
A new health policy roadmap has been published in The Lancet – calling on governments to shake-up care for debilitating osteoarthritis. Led by Professor Andrew Briggs from Curtin University, the research brought together experts from 18 countries, including Professors Lyn March and David Hunter, and Dr Saurab Sharma from the Kolling Institute and the University…
-
Emerging therapies offer hope following spinal cord injury
Posted on:
Leading investigator Professor Jane Butler believes a combination of exciting new therapies will see the biggest gains for people living with a spinal cord injury. Professor Butler is internationally known for her research into spinal cord injury, specifically the neural control of respiration and neurorehabilitation after injury. Jane and her team of 12 recently relocated…
-
Landmark trial confirms benefits of physiotherapist-led emergency care
Posted on:
Clinician researchers at the Kolling Institute supported a large-scale trial which found that physiotherapist-led care significantly reduced emergency department waiting and treatment times for people with musculoskeletal conditions. Close to 1500 patients were involved in the trial across five emergency departments, with patients receiving either standard care by emergency physicians or nurse practitioners – or…
-
Kolling expertise secures funding to tackle some of our biggest health challenges
Posted on:
Internationally-recognised clinician researcher Professor Gemma Figtree will lead a Centre of Research Excellence to reduce heart attacks after securing a highly-competitive $3 million National Health and Medical Research Council grant. The research will aim to save lives by detecting and treating silent coronary artery disease, the underlying cause of most heart attacks. Professor Figtree said…
-
Kolling Institute Year in Review 2025
Posted on:
Our Year in Review highlights the significant impact, collaboration and momentum across the Kolling Institute, and comes as we mark an important milestone with the launch of our 2026–2030 Research Strategy. Kolling researchers achieved great success in 2025, expanding the scale, reach and influence of their research across their discovery, translational and clinical disciplines. These achievements…
-
Researchers unveil the key to ageing well
Posted on:
Clinical and research experts across the Kolling Institute passionately discussed the potential of their research to provide crucial new knowledge and effective treatments to support healthy ageing during a recent event. Hosted by the NORTH Foundation, more than 150 people came together for the Living Longer, Living Better showcase, including donors, supporters and health professionals.…
-
Landmark gift to drive new knowledge and reduce pancreatic cancer toll
Posted on:
Internationally-recognised investigator Professor Marina Pajic has begun her new role as the Paul and Katherine Gobits (Koh) Chair of Pancreatic Cancer Research determined to accelerate research into one of Australia’s most challenging cancers. Based at the Kolling Institute, Professor Pajic will be working within the University of Sydney. Her position follows a remarkable $11 million…
Primary Research Area/s: Research Excellence -
New strategy to escalate research impact and deliver world leading care
Posted on:
More than 150 people came together for the launch of the Kolling Institute’s Research Strategy 2026-2030, a roadmap to strengthen research expertise and expand access to high-value care. Developed through extensive consultation with researchers, clinicians, consumers, and partners, the strategy provides a framework to guide future growth, innovation and impact. Academic Director Professor James Elliott…
Primary Research Area/s: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence -
Internationally-recognised researchers join the Kolling
Posted on:
Our cancer and musculoskeletal expertise has been strengthened with the appointment of two senior researchers and their teams to the Kolling Institute. Professor Marina Pajic has been appointed the Paul and Katherine Gobits (Koh) Chair of Pancreatic Cancer Research following a remarkable $11 million gift. It is the largest individual philanthropic gift to pancreatic cancer research in Australia.…
-
New funding to shift fragmented osteoarthritis care towards prevention, earlier prediction and better outcomes
Posted on:
The unique expertise of our osteoarthritis researchers at the Kolling Institute has been recognised, with world-leading clinician researcher Professor David Hunter receiving a remarkable $3 million NHMRC Leadership Investigator Grant. These grants are the NHMRC’s flagship funding scheme, offering valuable research support and flexibility. They are highly competitive, with just 234 of the nearly 1,900…
Primary Research Area/s: Research Excellence
